Chemoinformaics analysis of 3-ETHYL-2-METHYLHEXANE
| Molecular Weight | 128.259 | nRot | 4 |
| Heavy Atom Molecular Weight | 108.099 | nRig | 0 |
| Exact Molecular Weight | 128.156 | nRing | 0 |
| Solubility: LogS | -4.61 | nHRing | 0 |
| Solubility: LogP | 4.477 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 28.3659 |
| nHD | 0 | BPOL | 20.0641 |
| QED | 0.544 |
| Synth | 2.551 |
| Natural Product Likeliness | 1.218 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.01 |
| HIA | 0.004 |
| CACO-2 | -4.22 |
| MDCK | 0.0000176 |
| BBB | 0.837 |
| PPB | 0.951541 |
| VDSS | 2.388 |
| FU | 0.0425368 |
| CYP1A2-inh | 0.669 |
| CYP1A2-sub | 0.863 |
| CYP2c19-inh | 0.229 |
| CYP2c19-sub | 0.936 |
| CYP2c9-inh | 0.524 |
| CYP2c9-sub | 0.668 |
| CYP2d6-inh | 0.026 |
| CYP2d6-sub | 0.18 |
| CYP3a4-inh | 0.149 |
| CYP3a4-sub | 0.414 |
| CL | 9.706 |
| T12 | 0.266 |
| hERG | 0.019 |
| Ames | 0.006 |
| ROA | 0.037 |
| SkinSen | 0.088 |
| Carcinogencity | 0.04 |
| EI | 0.989 |
| Respiratory | 0.207 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.934314 |